Vaccinex Inc (VCNX)
5.30
-0.32
(-5.78%)
USD |
NASDAQ |
May 16, 12:35
Vaccinex Profit Margin (Quarterly)
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
Date | Value |
---|---|
September 30, 2023 | -24.56K% |
June 30, 2023 | |
March 31, 2023 | -902.2% |
December 31, 2022 | -2.26K% |
September 30, 2022 | -9.52K% |
June 30, 2022 | |
March 31, 2022 | |
December 31, 2021 | |
September 30, 2021 | -10.41K% |
June 30, 2021 | |
March 31, 2021 | -773.4% |
December 31, 2020 |
Date | Value |
---|---|
September 30, 2020 | -17.51K% |
June 30, 2020 | |
March 31, 2020 | |
December 31, 2019 | |
September 30, 2019 | -1.89K% |
June 30, 2019 | -35.31K% |
March 31, 2019 | -9.65K% |
December 31, 2018 | -4.36K% |
September 30, 2018 | -3.33K% |
June 30, 2018 | -5.24K% |
March 31, 2018 | -3.82K% |
December 31, 2017 | -2.88K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-35.31K%
Minimum
Jun 2019
-773.4%
Maximum
Mar 2021
-11.46K%
Average
-9.52K%
Median
Sep 2022
Profit Margin (Quarterly) Benchmarks
Emergent BioSolutions Inc | 3.08% |
Avinger Inc | -263.6% |
RAPT Therapeutics Inc | -- |
NovaBay Pharmaceuticals Inc | -122.2% |
Palatin Technologies Inc | -385.6% |